Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 07, 2026 05:00 ET | Source: Scenic Biotech

Scenic Biotech Enters License and Research Agreement with Ono Pharmaceutical

Scenic enters license and research agreement with Ono Pharmaceutical to utilize Scenic’s Cell-Seq platform for the discovery of novel therapeutics
June 25, 2019 08:00 ET | Source: Rafael Pharmaceutical Inc.

Rafael Pharmaceuticals Enters into Out-Licensing Agreement with Ono Pharmaceutical to Accelerate Clinical Development and Commercialization of Cancer Drug Candidate CPI-613® (devimistat) in Japan and Other Asian Countries

Cranbury, NJ, June 25, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, announced today that...